Novel Siderophore Cephalosporin Nets Promising Results in Tough-to-Treat CRAB

MedPage Today) — WASHINGTON – Cefiderocol (Fetroja) may be a viable targeted-therapy option in critically ill patients with carbapenem-resistant Acinetobacter baumannii infections (CRAB), according to the ongoing PROVE trial.
In the real…
Read More